BioCentury
ARTICLE | Clinical News

ALKS 8700: Phase I data

November 9, 2015 8:00 AM UTC

A double-blind, crossover Phase I trial in 35 healthy volunteers showed that a single dose of ALKS 8700 was bioequivalent to a single dose of Tecfidera dimethyl fumarate. The most common ALKS 8700-re...